AbstractObjectives18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) is a useful tool for evaluating inflammation. Because, myocardial-FDG uptake occurs with diverse physiology, it should be suppressed during evaluation of myocardial inflammation by FDG-PET/CT. Diets inducing fat-based metabolism, such as a low-carbohydrate, high-fat diet (LCHF), are used in uptake-suppression protocols. However, a complete suppression of myocardial-FDG uptake has not been established. Hence, we assessed the efficacy of 24-h carbohydrate restriction along with an LCHF diet compared to that of the conventional protocol in suppressing myocardial-FDG uptake and also compared fat and glucose metabolism between these protoco...
Background: Positron emission tomography (PET) with 18F fluorodeoxyglucose (FDG) is used in evaluati...
Background: F-fluorodeoxyglucose (F-FDG) positron emission tomography (PET) is used in the diagnosis...
Background: There are two main myocardial metabolic pathways including glucose oxidative pathway and...
Low-carbohydrate (LC) and high-fat, low-carbohydrate (HFLC) dietary preparations may enhance 18F-FDG...
Background: 18F-FDG PET/CT is a promising method for imaging coronary atherosclerotic plaque inflamm...
Patients prepared by the generally used fasting protocol show variable myocardial 18F-FDG uptake, wh...
Introduction: Adequate suppression of physiologic myocardial glucose uptake is important to ensure t...
Background: 18F-FDG-PET/CT is a promising approach for imaging atherosclerotic plaque inflammation. ...
INTRODUCTION: Suppression of physiological myocardial FDG activity is vital in patients undergoing P...
Adequate suppression of cardiac glucose metabolism increases the interpretability and diagnostic rel...
Adequate suppression of cardiac glucose metabolism increases the interpretability and diagnostic rel...
(18)F-FDG PET/CT can be used to detect arterial atherosclerotic plaque inflammation. However, avid m...
Background The major challenge in diagnosing infective endocarditis using 18fluorine-fluorodeoxygluc...
Background: 18F-fluorodeoxyglucose (FDG) PET/CT plays an important role to detect active cardiac inv...
(18)F-fluorodeoxyglucose (FDG) PET plays an important role in the detection of cardiac involvement s...
Background: Positron emission tomography (PET) with 18F fluorodeoxyglucose (FDG) is used in evaluati...
Background: F-fluorodeoxyglucose (F-FDG) positron emission tomography (PET) is used in the diagnosis...
Background: There are two main myocardial metabolic pathways including glucose oxidative pathway and...
Low-carbohydrate (LC) and high-fat, low-carbohydrate (HFLC) dietary preparations may enhance 18F-FDG...
Background: 18F-FDG PET/CT is a promising method for imaging coronary atherosclerotic plaque inflamm...
Patients prepared by the generally used fasting protocol show variable myocardial 18F-FDG uptake, wh...
Introduction: Adequate suppression of physiologic myocardial glucose uptake is important to ensure t...
Background: 18F-FDG-PET/CT is a promising approach for imaging atherosclerotic plaque inflammation. ...
INTRODUCTION: Suppression of physiological myocardial FDG activity is vital in patients undergoing P...
Adequate suppression of cardiac glucose metabolism increases the interpretability and diagnostic rel...
Adequate suppression of cardiac glucose metabolism increases the interpretability and diagnostic rel...
(18)F-FDG PET/CT can be used to detect arterial atherosclerotic plaque inflammation. However, avid m...
Background The major challenge in diagnosing infective endocarditis using 18fluorine-fluorodeoxygluc...
Background: 18F-fluorodeoxyglucose (FDG) PET/CT plays an important role to detect active cardiac inv...
(18)F-fluorodeoxyglucose (FDG) PET plays an important role in the detection of cardiac involvement s...
Background: Positron emission tomography (PET) with 18F fluorodeoxyglucose (FDG) is used in evaluati...
Background: F-fluorodeoxyglucose (F-FDG) positron emission tomography (PET) is used in the diagnosis...
Background: There are two main myocardial metabolic pathways including glucose oxidative pathway and...